21 results on '"Schepis, F."'
Search Results
2. BOC.02.7: UNDERDILATED NEOADJUVANT-TIPS IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION CANDIDATES TO OPERATIVE INTERVENTIONS
3. BOC.02.4: EPISODIC OVERT HEPATIC ENCEPHALOPATHY AFTER TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT DOES NOT INCREASE MORTALITY IN PATIENTS WITH CIRRHOSIS
4. OC.05.2: FIRST AND FURTHER LIVER DECOMPENSATION IN PATIENTS WITH METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE: WHAT CLINICAL IMPACT?
5. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis
6. A machine learning enabled score based on large varices predicts 5- and 10-year hepatocellular carcinoma (HCC) development in a 12-year prospective cohort of patients with compensated advanced chronic liver disease
7. Serum procalcitonin predicts mortality independently of the presence of ACLF in patients with cirrhosis and ascites hospitalized for suspicious infection and treated with empiric antibiotic therapy
8. Presence and severity of esophageal varices drives portal hypertension-related complications in compensated advanced nonalcoholic fatty liver disease
9. TIPS under-dilation strategy with new controlled expansion endoprosthesis: A hemodynamic and imaging confirmation of its feasibility
10. Transjugular intra-hepatic portosystemic shunt (TIPS) in elderly patients: preliminary analysis of a multicenter retrospective cohort.
11. Underdilated neoadjuvant-TIPS in patients with cirrhosis and portal hypertension candidates to operative interventions
12. External Validation of the ExPeCT TIPS Prediction Model in a North American Cohort
13. First and further liver decompensation in patients with metabolic-dysfunction associated steatotic liver disease: what clinical impact?
14. Underdilation strategy for TIPS placement reduces incidence of overt hepatic encephalopathy without affecting clinical efficacy and survival: results of a multicenter prospective Italian study
15. End-procedural complete haemodynamic response may not be essential for the clinical success of TIPS in patients with cirrhosis
16. Long-term prospective study of development of hepatocellular carcinoma in compensated cirrhosis
17. Clinical presentation and etiological spectrum of idiopathic non-cirrhotic portal hypertension (INCPH): data from the Italian Registry
18. Low Molecular Weight Heparin (LMWH) treatment does not increase the risk of bleeding after prophylactic endoscopic variceal band ligation in patients with cirrhosis
19. Progressive alterations of cardiopulmonary hemodynamics accompanied by increasing levels of C reactive protein (CRP) occur in patients in different stages of cirrhosis and predict death in decompensated cirrhosis
20. 15 P Preoperative radiotherapy and chemotherapy in patients with esophageal carcinoma: A meta-analysis
21. Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.